<code id='1B53F33677'></code><style id='1B53F33677'></style>
      • <acronym id='1B53F33677'></acronym>
      <center id='1B53F33677'><center id='1B53F33677'><tfoot id='1B53F33677'></tfoot></center><abbr id='1B53F33677'><dir id='1B53F33677'><tfoot id='1B53F33677'></tfoot><noframes id='1B53F33677'>
      • <optgroup id='1B53F33677'><strike id='1B53F33677'><sup id='1B53F33677'></sup></strike><code id='1B53F33677'></code></optgroup>
        5. <b id='1B53F33677'><label id='1B53F33677'><select id='1B53F33677'><dt id='1B53F33677'><span id='1B53F33677'></span></dt></select></label></b><u id='1B53F33677'></u>
          <i id='1B53F33677'><strike id='1B53F33677'><tt id='1B53F33677'><pre id='1B53F33677'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / explore / hotspot      
           
     
           
      
          hotspot 
           
      
           
      
           
       2025-09-30 09:27:21 
   
      
           
      
           
                        
          hotspot  
          
                                   
                 
                                      author：Wikipedia   
                                        
                                      
                                      Page View：413
                                  
                                    
          
                                   
          Cambridge: AbbVie
          The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 — nearly a million dollars more than the company has ever spent in a single quarter. 																									Ruby Wallau for STAT
          WASHINGTON — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 alone — more than any other drugmaker spent in the same period, and nearly a million dollars more than the company spent in the same period last year.
          AbbVie was the seventh-highest corporate lobbying spender last quarter, ahead of giants like Lockheed Martin, CVS Health, and, AT&T, federal records show.
          advertisement
          The number is eye-popping even for the pharmaceutical industry, which is known for its omnipresence on Capitol Hill, and its nearly unlimited lobbying budgets.
          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!					
          GET STARTED													Log In											
                      
                              
          
                                 Previous article：

                                
                                          GSK Flovent asthma inhalers replaced by authorized generics
                                
                            
          Next article：  
                                      
                                          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles